Navigation Links
Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
Date:2/4/2010

FORT WORTH, Texas, Feb. 4 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced today that its subsidiary Secure eHealth LLC has completed a consulting agreement with GSI Health.  GSI Health is led by Leroy E. Jones, who is a principal and Chief Executive Officer. Under the Consulting Agreement , GSI Health will focus primarily on the market penetration and development of Secure eHealth's suite of secure messaging, authentication and notification products. "We are looking forward to benefiting a great deal from Lee's expertise in the market to help boost our penetration into the healthcare space with these products.  Having someone with his experience guiding us will assist us in getting to the top of the list of security solutions in an industry where it is so desperately needed," says Deborah Jenkins-Hutchinson, Wound Management Technologies president.

Mr. Jones is a healthcare technology executive with broad experience delivering technical solutions across the health-industry spectrum, including pharmaceuticals, acute care delivery, managed care, public health, and health informatics generally. In his year-long engagement as Senior Advisor to Dr. David J. Brailer, National Coordinator for Health Information Technology, Mr. Jones was responsible for managing the strategic technical directions for the national healthcare agenda. He was one of the inaugural members of the ONCHIT team. Mr. Jones was responsible for leading the effort to build technical infrastructure for nationwide interoperability. Mr. Jones is a recognized healthcare industry expert, and a sought-after public speaker. A sampling of organizations where Mr. Jones has addressed audiences at major conferences includes: National Association of State
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
3. Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
4. GeoVax Secures $10 Million Financing Commitment
5. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
6. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
7. ALung Secures $2.5 Million
8. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
9. Minnesota High School Tournament Sidelines to be More Secure From Sudden Cardiac Arrest
10. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
11. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... 12, 2011 Unilife Corporation ("Unilife" or the "Company") ... the development of its AutoInfusor™ portfolio of subcutaneous infusion ... 5mL, 7mL, and 10mL volumes. Unilife has ... of pharmaceutical and biotechnology companies with drugs that have ...
... one of the largest distributors of high-performance and engineering-grade ... new EVONIK VESTAKEEP® 5000 PEEK extruded stock shapes. ... most ductility of any PEEK material available in extruded ... Marketing at Modern Plastics. EVONIK VESTAKEEP® ...
Cached Medicine Technology:Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 2Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 3Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 4
(Date:5/18/2013)... PA (PRWEB) May 18, 2013 Simple ... indulging in healthy snacks and drinking more water can ... loss and, ultimately, a healthier lifestyle overall. Diet ... achieve the best weight loss can be difficult and ... into their diet plans to help patients get over ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment ... “K2” are landing in emergency rooms across America. ... epidemic with a new treatment program for those ... research from the National Institute on Drug Abuse, synthetic ... American teenagers. In 2012, 11 percent of high school ...
(Date:5/18/2013)... Francisco, CA (PRWEB) May 18, 2013 ... appointments for 2013 therapies. At the Ayurvedic Spa ... guidance of panchakarma practitioner and lifestyle recommendations ... Ayurveda, the “knowledge of life", is the traditional healthcare ... that a life of harmony is the basis for ...
(Date:5/18/2013)... May 18, 2013 Losing weight remains to ... among the horde of new weight loss products available in ... about. Recent studies about this newest weight loss supplement prove ... body shape. , Garcinia Cambogia is a sub-tropical fruit that ... Eating the fruit can suppress a person’s appetite, while it ...
(Date:5/18/2013)... Scott Tischler of Tischler Brothers Fitness helped Troy Tischler ... losing weight played a huge part in Troy Tischler's weight ... was able to lose a pound a day. It is ... approached with caution and any activity should be stopped if ... weight loss that Scott Tischler advocates. With these five keys ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2
... ... inactivating 99.9% of the flu virus. The filter has been treated with Coway,s anti-viral ... ... 2009 -- Coway ,s new anti-flu air filter was recently tested for ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), ... nursing, rehabilitative care services, hospice care and assisted living ... Oppenheimer & Co. 20th Annual Healthcare Conference on November ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the company,s ...
... Keystone ... and administer health screenings. , ... Philadelphia, Pa. October 27, 2009 – More than 250 West Philadelphia men, ... part of the Health Ministry Program, hosted by Keystone Mercy Health Plan, the largest ...
... ... an Impact as Inaugural President , ... Grand Rapids, Mich. (Vocus) October 29, 2009 -- Sanford-Brown Institute (SBI) - Grand ... first campus president. Amidon comes to SBI - Grand Rapids from Baker College in Muskegon, ...
... Smith & Nephew,s (NYSE: SNN ; LSE: ... first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement ... Smith & Nephew and COTA entered into a grant ... as an independent, third-party administrator of funds. Smith ...
... autoimmune disease scleroderma can discolor parts of the skin of ... harden their skin, their blood vessels, and their internal organs ... forms, scleroderma gives Dartmouth geneticist Michael Whitfield, his graduate students, ... search for the triggers of the chronic condition. In a ...
Cached Medicine News:Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2Health News:More Than 250 West Philadelphia Men, Women and Children are Expected to Attend Wellness for Life Event 2Health News:President Selected to Open Sanford-Brown Institute - Grand Rapids 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 3Health News:Geneticists hunt for scleroderma triggers 2
Prolactin EIA Reproductive Markers 025-BC-1037...
FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone...
... (pregn-4-ene-3, 20-dione) is a C21 steroid hormone ... bond between C-4 and C-5 (?4).,This steroid ... in conjunction with estrogens, regulates,the accessory organs ... particularly important in preparing the,endometrium for the ...
... also known as Kininase II, is a ... weight of at least 129,000. The structure ... chain, a polysaccharide residue and a zinc ... cell types such as neuronal cells and ...
Medicine Products: